BioPharma
J&J To Be in Sync with Trump Administration as MFN Spreads
As the two Trump administration drug pricing deals find their place in the books and more that are likely on the way, the U.S....
News
The Importance of Solar Energy in Securing a Sustainable Future for the Pharmaceutical Industry
In a time when sustainability and environmental consciousness are at the forefront of our global priorities, industries seek greener and cleaner energy solutions. The...
BioPharma
Investments in the U.S. of Over $70bn Announced by Merck
It is well to be noted that in 2025, a minimum of 14 major pharmaceutical companies across the world went ahead and announced plans...
News
Pharmaceutical Manufacturing Fire Safety Through Skilled Workforce Training
Pharmaceutical manufacturing environments handle a variety of sensitive and potentially hazardous materials every day. These include solvents, flammable chemicals, pressurized gases, and high-temperature equipment,...
BioPharma
LTS Grows U.S. Footprint by Buying CDMO Renaissance Lakewood
As the U.S. production investments continue to roll in 2025, LTS Lohmann, the German pharmaceutical technology specialist, is joining the table with a deal...
BioPharma
US Tariffs on Pharma Exports from Singapore Deferred
As originally reported by the Straits Times and also shared by Reuters, the enforcement of US tariffs on pharma exports from Singapore is being deferred so...
Industry Reports
UK Exchequer Wants More Pharma Investment Coming in Britain
Rachel Reeves, the UK Chancellor of the Exchequer, has asked more pharma investment coming in Britain, even as she doubles down on the commitment...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read